Clinical trial
Prospective Single-Arm Clinical Study of Thiotepa-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia
NCT07588594 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Single-Arm Clinical Study of Thiotepa-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 13, 2026
- Completion date
- May 31, 2028
- Enrollment
- 31 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myelomonocytic leukemia (cmml)